Allied Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Allied Biotech has a total shareholder equity of NT$1.2B and total debt of NT$820.2M, which brings its debt-to-equity ratio to 70.9%. Its total assets and total liabilities are NT$2.2B and NT$1.0B respectively. Allied Biotech's EBIT is NT$85.1M making its interest coverage ratio -11.1. It has cash and short-term investments of NT$886.5M.
Key information
70.9%
Debt to equity ratio
NT$820.23m
Debt
| Interest coverage ratio | -11.1x |
| Cash | NT$886.51m |
| Equity | NT$1.16b |
| Total liabilities | NT$1.03b |
| Total assets | NT$2.19b |
Recent financial health updates
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well
Mar 05
Is Allied Biotech (GTSM:1780) A Risky Investment?
Nov 25Recent updates
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?
Apr 16These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well
Mar 05Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment
Jan 24Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?
Jan 03A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)
Dec 13
Is Allied Biotech (GTSM:1780) A Risky Investment?
Nov 25Financial Position Analysis
Short Term Liabilities: 1780's short term assets (NT$1.6B) exceed its short term liabilities (NT$959.2M).
Long Term Liabilities: 1780's short term assets (NT$1.6B) exceed its long term liabilities (NT$71.0M).
Debt to Equity History and Analysis
Debt Level: 1780 has more cash than its total debt.
Reducing Debt: 1780's debt to equity ratio has increased from 44.4% to 70.9% over the past 5 years.
Debt Coverage: 1780's debt is well covered by operating cash flow (26%).
Interest Coverage: 1780 earns more interest than it pays, so coverage of interest payments is not a concern.